Literature DB >> 23061075

Position paper by Canadian dental sleep medicine professionals on the role of different health care professionals in managing obstructive sleep apnea and snoring with oral appliances.

Luc Gauthier1, Fernanda Almeida, Jean-Patrick Arcache, Catherine Ashton-McGregor, David Coté, Helen S Driver, Kathleen A Ferguson, Gilles J Lavigne, Philippe Martin, Jean-François Masse, Florence Morisson, Jeffrey Pancer, Charles Harry Samuels, Maurice Schachter, Frédéric Sériès, Glendon Edward Sullivan.   

Abstract

The present Canadian position paper contains recommendations for the management by dentists of sleep-disordered breathing in adults with the use of oral appliances (OAs) as a treatment option for snoring and obstructive sleep apnea (OSA). The recommendations are based on literature reviews and expert panel consensus. OAs offer an effective, first-line treatment option for patients with mild to moderate OSA who prefer an OA to continuous positive airway pressure (CPAP) therapy, or for severe OSA patients who cannot tolerate CPAP, are inappropriate candidates for CPAP or who have failed CPAP treatment attempts. The purpose of the present position paper is to guide interdisciplinary teamwork (sleep physicians and sleep dentists) and to clarify the role of each professional in the management of OA therapy. The diagnosis of OSA should always be made by a physician, and OAs should be fitted by a qualified dentist who is trained and experienced in dental sleep medicine. Follow-up assessment by the referring physician and polysomnography or sleep studies are required to verify treatment efficacy. The present article emphasizes the need for a team approach to OA therapy and provides treatment guidelines for dentists trained in dental sleep medicine. Many of the dentists and sleep physicians who contributed to the preparation of the present article are members of the Canadian Sleep Society and the authors reached a consensus based on the current literature.

Entities:  

Mesh:

Year:  2012        PMID: 23061075      PMCID: PMC3473005          DOI: 10.1155/2012/631803

Source DB:  PubMed          Journal:  Can Respir J        ISSN: 1198-2241            Impact factor:   2.409


  8 in total

1.  [Practice Guidelines of the Canadian Thoracic Society on the diagnosis and treatment of sleep respiratory problems of adults].

Authors:  John Fleetham; Najib Ayas; Doug Bradley; Kathy Ferguson; Michael Fitzpatrick; Charlie George; Patrick Hanly; Fran Hill; John Kimoff; Meir Kryger; Debra Morrison; Frederic Series; Willis Tsai
Journal:  Can Respir J       Date:  2007 Jan-Feb       Impact factor: 2.409

Review 2.  Oral appliance treatment of obstructive sleep apnea: an update.

Authors:  Andrew S L Chan; Peter A Cistulli
Journal:  Curr Opin Pulm Med       Date:  2009-11       Impact factor: 3.155

3.  A short-term controlled trial of an adjustable oral appliance for the treatment of mild to moderate obstructive sleep apnoea.

Authors:  K A Ferguson; T Ono; A A Lowe; S al-Majed; L L Love; J A Fleetham
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

4.  Non-CPAP therapies in obstructive sleep apnoea.

Authors:  W J Randerath; J Verbraecken; S Andreas; G Bettega; A Boudewyns; E Hamans; F Jalbert; J R Paoli; B Sanner; I Smith; B A Stuck; L Lacassagne; M Marklund; J T Maurer; J L Pepin; A Valipour; T Verse; I Fietze
Journal:  Eur Respir J       Date:  2011-03-15       Impact factor: 16.671

5.  Practice parameters for the use of portable monitoring devices in the investigation of suspected obstructive sleep apnea in adults.

Authors:  Andrew L Chesson; Richard B Berry; Allan Pack
Journal:  Sleep       Date:  2003-11-01       Impact factor: 5.849

6.  Practice parameters for the treatment of snoring and Obstructive Sleep Apnea with oral appliances: an update for 2005.

Authors:  Clete A Kushida; Timothy I Morgenthaler; Michael R Littner; Cathy A Alessi; Dennis Bailey; Jack Coleman; Leah Friedman; Max Hirshkowitz; Sheldon Kapen; Milton Kramer; Teofilo Lee-Chiong; Judith Owens; Jeffrey P Pancer
Journal:  Sleep       Date:  2006-02       Impact factor: 5.849

7.  Successful treatment of upper airway resistance syndrome with an oral appliance.

Authors:  D I Loube; T Andrada; N Shanmagum; M T Singer
Journal:  Sleep Breath       Date:  1997-12       Impact factor: 2.816

8.  Position paper on the use of mandibular advancement devices in adults with sleep-related breathing disorders. A position paper of the German Society of Dental Sleep Medicine (Deutsche Gesellschaft Zahnaerztliche Schlafmedizin, DGZS).

Authors:  Susanne Schwarting; Ulrich Huebers; Markus Heise; Joerg Schlieper; Andreas Hauschild
Journal:  Sleep Breath       Date:  2007-06       Impact factor: 2.816

  8 in total
  6 in total

1.  Evaluation of the impact of a clinical pathway on the organization of a multidisciplinary dental sleep clinic.

Authors:  D M Ten Berge; M J Braem; A Altenburg; M Dieltjens; P H Van de Heyning; K Vanhaecht; O M Vanderveken
Journal:  Sleep Breath       Date:  2013-09-03       Impact factor: 2.816

2.  Oral appliances, position papers and sleep disorders.

Authors:  John A Fleetham
Journal:  Can Respir J       Date:  2012 Sep-Oct       Impact factor: 2.409

Review 3.  Diagnosis and treatment of obstructive sleep apnea in adults.

Authors:  Cheryl R Laratta; Najib T Ayas; Marcus Povitz; Sachin R Pendharkar
Journal:  CMAJ       Date:  2017-12-04       Impact factor: 8.262

Review 4.  An update on mandibular advancement devices for the treatment of obstructive sleep apnoea hypopnoea syndrome.

Authors:  Shadi Basyuni; Michal Barabas; Tim Quinnell
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

5.  Efficacy of uvulopalatopharyngoplasty combined with oral appliance in treatment of obstructive sleep apnea-hypopnea syndrome.

Authors:  D Yang; H-F Zhou; Y Xie
Journal:  Ir J Med Sci       Date:  2014-04-16       Impact factor: 1.568

Review 6.  The face of Dental Sleep Medicine in the 21st century.

Authors:  Frank Lobbezoo; Gilles J Lavigne; Takafumi Kato; Fernanda R de Almeida; Ghizlane Aarab
Journal:  J Oral Rehabil       Date:  2020-08-29       Impact factor: 3.837

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.